R. Elaine Turner

On October 31, 2000, the Food and Drug Administration responded to the third of four proposed health claims for dietary supplements that were the subject of the infamous “Pearson decision” with a new twist in the health claims arena: a “qualified health claim” approved solely for a dietary supplement, and thus far only for the alleged relationship between omega-3 fatty acids and coronary heart disease (CHD).

The case of Pearson and Shaw v. Shalala challenged FDA’s 1993 decision to deny four heal…

Premium Content
You've reached your monthly limit of free articles.
Access Food Technology
Log in Subscribe